title: Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization.
abstract: OBJECTIVE
  To determine the incidence and features of macular retinal detachment (RD) after successful intravitreal injection of bevacizumab (IVB) for the treatment of myopic choroidal neovascularizations (CNVs).
  
  
  METHODS
  Seventy-four eyes of 74 patients who received IVB for myopic CNV were studied. Fluorescein angiography (FA) and optical coherence tomography (OCT) were performed at baseline, at 1 week after IVB, and every month thereafter. The shortest follow-up period was 6 months.
  
  
  RESULTS
  Four eyes (5.4%) either developed or had increased macular RD after successful IVB. In the three eyes, macular RD newly developed 1 month after IVB despite the absence of dye leakage. The remaining eye had a limited area of macular RD at baseline and increased despite the disappearance of dye leakage from the CNV after the IVB. The four eyes that developed a macular RD had retinoschisis around the CNV before IVB, whereas none of the 70 other patients had a retinoschisis throughout the follow-up period. In all four eyes that either developed or had increased macular RD, outer lamellar holes were detected at the upper edge of the RD by OCT examinations, whereas none of the patients who did not develop a macular RD after IVB showed outer lamellar holes.
  
  
  CONCLUSIONS
  These results suggest that there is a risk of developing macular RD after IVB in eyes with myopic CNV. Periodic OCT examinations are recommended for patients with myopic CNV to search for RDs after IVB.
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
authors: Noriaki
authors: N
authors: Shimada
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. k.ohno.oph@tmd.ac.jp.
authors: Kyoko
authors: K
authors: Ohno-Matsui
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
authors: Kengo
authors: K
authors: Hayashi
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
authors: Takeshi
authors: T
authors: Yoshida
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
authors: Takashi
authors: T
authors: Tokoro
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
authors: Manabu
authors: M
authors: Mochizuki
references: Ophthalmology. 2007 Dec;114(12):2190-6
references: 17599414
references: Am J Ophthalmol. 1971 Jan;71(1 Pt 1):42-53
references: 5099937
references: Br J Ophthalmol. 2009 Feb;93(2):150-4
references: 18801766
references: Korean J Ophthalmol. 2007 Sep;21(3):185-7
references: 17804928
references: Br J Ophthalmol. 2007 Feb;91(2):161-5
references: 16914470
references: Br J Ophthalmol. 2008 Jun;92(6):762-4
references: 18523081
references: Br J Ophthalmol. 2007 Feb;91(2):157-60
references: 16870653
references: Am J Ophthalmol. 2005 Jan;139(1):197-9
references: 15652854
references: Arch Ophthalmol. 2008 Jul;126(7):941-5
references: 18625940
references: Am J Ophthalmol. 1997 Feb;123(2):181-7
references: 9186123
references: Am J Ophthalmol. 2009 Jan;147(1):94-100.e1
references: 18774550
references: Arch Ophthalmol. 2004 Oct;122(10):1455-60
references: 15477456
references: Am J Ophthalmol. 2010 Mar;149(3):458-64.e1
references: 20172072